NO20012534L - Anvendelse av parvoviruskapsidpartikler ved inhiberingen av celleproliferering og migrering - Google Patents

Anvendelse av parvoviruskapsidpartikler ved inhiberingen av celleproliferering og migrering

Info

Publication number: NO20012534L
Authority: NO; Norway
Prior art keywords: cells; migration; parvoviral capsid; inhibition; cell proliferation
Prior art date: 1998-11-24

Application number

NO20012534A

Other languages

English (en)

Norwegian (no)

Other versions

NO20012534D0 (no

Inventor

Kristina Broliden

Magnus Westgren

Original Assignee

Magnus Westgren

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-24

Filing date

2001-05-23

Publication date

2001-06-29

2001-05-23 Application filed by Magnus Westgren filed Critical Magnus Westgren

2001-05-23 Publication of NO20012534D0 publication Critical patent/NO20012534D0/no

2001-06-29 Publication of NO20012534L publication Critical patent/NO20012534L/no

Links

210000000234 capsid Anatomy 0.000 title abstract 2
238000013508 migration Methods 0.000 title abstract 2
239000002245 particle Substances 0.000 title abstract 2
230000013152 negative regulation of cell migration Effects 0.000 title 1
230000035407 negative regulation of cell proliferation Effects 0.000 title 1
210000004027 cell Anatomy 0.000 abstract 3
239000000427 antigen Substances 0.000 abstract 2
102000036639 antigens Human genes 0.000 abstract 2
108091007433 antigens Proteins 0.000 abstract 2
230000010261 cell growth Effects 0.000 abstract 2
210000002889 endothelial cell Anatomy 0.000 abstract 2
108090000565 Capsid Proteins Proteins 0.000 abstract 1
102100023321 Ceruloplasmin Human genes 0.000 abstract 1
230000002159 abnormal effect Effects 0.000 abstract 1
208000017733 acquired polycythemia vera Diseases 0.000 abstract 1
230000000259 anti-tumor effect Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
230000003176 fibrotic effect Effects 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
230000012010 growth Effects 0.000 abstract 1
230000003394 haemopoietic effect Effects 0.000 abstract 1
210000003958 hematopoietic stem cell Anatomy 0.000 abstract 1
238000002513 implantation Methods 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000005012 migration Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
208000037244 polycythemia vera Diseases 0.000 abstract 1
230000035755 proliferation Effects 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
208000037803 restenosis Diseases 0.000 abstract 1
238000011476 stem cell transplantation Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Virology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Surgery (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO20012534A 1998-11-24 2001-05-23 Anvendelse av parvoviruskapsidpartikler ved inhiberingen av celleproliferering og migrering NO20012534L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9804022A SE520177C2 (sv)	1998-11-24	1998-11-24	Användning av tomma, icke-infektiösa, rekombinanta parvoviruskapsidpartiklar, eller P-antigenblockerande delar därav, för framställning av läkemedel för ihibering av hematopoietiska stamceller
PCT/IB1999/002112 WO2000030668A2 (fr)	1998-11-24	1999-11-23	Utilisation de particules de capsides de parvovirus dans l'inhibition de la proliferation et de la migration cellulaire

Publications (2)

Publication Number	Publication Date
NO20012534D0 NO20012534D0 (no)	2001-05-23
NO20012534L true NO20012534L (no)	2001-06-29

Family

ID=20413393

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20012534A NO20012534L (no)	1998-11-24	2001-05-23	Anvendelse av parvoviruskapsidpartikler ved inhiberingen av celleproliferering og migrering

Country Status (14)

Country	Link
EP (1)	EP1131085A2 (fr)
JP (1)	JP2003516927A (fr)
KR (1)	KR20010080518A (fr)
CN (1)	CN1328469A (fr)
AU (1)	AU2566600A (fr)
CA (1)	CA2352043A1 (fr)
CZ (1)	CZ20011369A3 (fr)
HU (1)	HUP0104298A2 (fr)
IS (1)	IS5931A (fr)
MX (1)	MXPA01004949A (fr)
NO (1)	NO20012534L (fr)
PL (1)	PL348640A1 (fr)
SE (1)	SE520177C2 (fr)
WO (1)	WO2000030668A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE345352T1 (de)	2001-07-10	2006-12-15	Deutsches Krebsforsch	Zusammensetzung einer parvovirus vp1- proteinvariante und eines arvovirus ns1-proteins zur induktion von zytolyse
US9573979B2 (en)	2004-09-24	2017-02-21	Susanne Modrow	Modified VP1-capsid protein of parvovirus B19
CN101475942B (zh) *	2008-11-28	2012-05-23	中国人民解放军第四军医大学	一种b19病毒vp1独特区基因
US9598468B2 (en)	2011-05-18	2017-03-21	University Of Florida Research Foundation, Incorporated	Polypeptides and vectors for targeting HER2/neu expressing cells and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2002839C (fr) *	1988-11-14	2000-10-10	Neal S. Young	Capsides de parvovirus
NL8902301A (nl) *	1989-09-14	1991-04-02	Rijksuniversiteit	Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.

1998
- 1998-11-24 SE SE9804022A patent/SE520177C2/sv not_active IP Right Cessation
1999
- 1999-11-23 CN CN99813653A patent/CN1328469A/zh active Pending
- 1999-11-23 KR KR1020017006374A patent/KR20010080518A/ko not_active Withdrawn
- 1999-11-23 PL PL99348640A patent/PL348640A1/xx unknown
- 1999-11-23 JP JP2000583551A patent/JP2003516927A/ja active Pending
- 1999-11-23 MX MXPA01004949A patent/MXPA01004949A/es unknown
- 1999-11-23 EP EP99968407A patent/EP1131085A2/fr not_active Withdrawn
- 1999-11-23 CZ CZ20011369A patent/CZ20011369A3/cs unknown
- 1999-11-23 HU HU0104298A patent/HUP0104298A2/hu unknown
- 1999-11-23 WO PCT/IB1999/002112 patent/WO2000030668A2/fr not_active Application Discontinuation
- 1999-11-23 AU AU25666/00A patent/AU2566600A/en not_active Abandoned
- 1999-11-23 CA CA002352043A patent/CA2352043A1/fr not_active Abandoned
2001
- 2001-05-02 IS IS5931A patent/IS5931A/is unknown
- 2001-05-23 NO NO20012534A patent/NO20012534L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2003516927A (ja)	2003-05-20
NO20012534D0 (no)	2001-05-23
SE520177C2 (sv)	2003-06-03
SE9804022D0 (sv)	1998-11-24
SE9804022L (sv)	2000-05-25
PL348640A1 (en)	2002-06-03
CA2352043A1 (fr)	2000-06-02
WO2000030668A2 (fr)	2000-06-02
EP1131085A2 (fr)	2001-09-12
WO2000030668A3 (fr)	2000-11-09
IS5931A (is)	2001-05-02
CZ20011369A3 (cs)	2001-10-17
AU2566600A (en)	2000-06-13
KR20010080518A (ko)	2001-08-22
WO2000030668A9 (fr)	2001-04-05
HUP0104298A2 (hu)	2002-03-28
MXPA01004949A (es)	2003-03-10
WO2000030668A8 (fr)	2000-09-14
CN1328469A (zh)	2001-12-26

Similar Documents

Publication	Publication Date	Title
Guo et al.	2018	Ubiquitin‐specific protease USP 34 controls osteogenic differentiation and bone formation by regulating BMP 2 signaling
Cummins et al.	2004	HAUSP is required for p53 destabilization
Roche et al.	2009	Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature
Solana et al.	1998	Molecular and cellular basis of immunosenescence
US10900018B2 (en)	2021-01-26	Means and methods for generation of breast stem cells
CN102858964A (zh)	2013-01-02	多肽
Stellavato et al.	2019	[Retracted] Novel Hybrid Gels Made of High and Low Molecular Weight Hyaluronic Acid Induce Proliferation and Reduce Inflammation in an Osteoarthritis In Vitro Model Based on Human Synoviocytes and Chondrocytes
Dogra et al.	2016	Generating long‐lived CD8+ T‐cell memory: Insights from epigenetic programs
Sanford et al.	1982	A quest for the mechanism of “spontaneous” malignant transformation in culture with associated advances in culture technology
Fikry et al.	2015	Bone marrow and adipose‐derived mesenchymal stem cells alleviate methotrexate‐induced pulmonary fibrosis in rat: comparison with dexamethasone
Yang et al.	2016	l‐Glutathione enhances antioxidant capacity of hyaluronic acid and modulates expression of pro‐inflammatory cytokines in human fibroblast‐like synoviocytes
Kumar et al.	2019	Nrf2 dependent antiaging effect of milk‐derived bioactive peptide in old fibroblasts
NO20012534L (no)	2001-06-29	Anvendelse av parvoviruskapsidpartikler ved inhiberingen av celleproliferering og migrering
Zander et al.	2004	Immortalized mouse cell lines that lack a functional Rev3 gene are hypersensitive to UV irradiation and cisplatin treatment
BR112022004562A2 (pt)	2022-06-07	Método de seleção de doador universal para identificar doadores de células nk
Rakonczay Jr et al.	2014	Chronic inflammation in the pancreas and salivary glands-lessons from similarities and differences in pathophysiology and treatment modalities
NO20060019L (no)	2006-03-03	Fremgangsmater og preparater for interferonterapi
Zhang et al.	2020	RSK-3 promotes cartilage regeneration via interacting with rpS6 in cartilage stem/progenitor cells
Koch et al.	2014	Modeling AEC—new approaches to study rare genetic disorders
Zhou et al.	2024	Enhancing Endogenous Hyaluronic Acid in Osteoarthritic Joints with an Anti‐Inflammatory Supramolecular Nanofiber Hydrogel Delivering HAS2 Lentivirus
Brzóska et al.	2009	Pax3 and Pax7 expression during myoblast differentiation in vitro and fast and slow muscle regeneration in vivo
Tang et al.	2016	Gene expression signatures associated with suppression of TRAMP prostate carcinogenesis by a kavalactone‐rich Kava fraction
Li et al.	2002	Signaling on telomerase: a master switch in cell aging and immortalization
Tohma et al.	2012	Osteogenic activity of bone marrow‐derived mesenchymal stem cells (BMSCs) seeded on irradiated allogenic bone
Mahiddine et al.	2016	CD99 isoforms regulate CD1a expression in human monocyte‐derived DCs through ATF‐2/CREB‐1 phosphorylation

Legal Events

Date	Code	Title	Description
2003-07-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application